U.S. Retail REITs Stock News

The Federal Reserve's revision to bank capital rules puts Citigroup in a stronger position by reducing regulatory hurdles and boosting confidence. In addition, the board has consolidated leadership under CEO Jane Fraser with a major equity award. See our latest analysis for Citigroup. Citigroup’s shares have surged in 2025, reflecting renewed investor optimism as the bank navigates easing regulatory headwinds and consolidates leadership under Jane Fraser. After a standout year-to-date share...

First Bancorp reported third-quarter results in October 2025, posting net interest income of US$102.49 million and net income of US$20.36 million, both above last year's figures. Adjusted earnings and revenue surpassed analyst expectations, highlighting the company’s ability to grow its income in a competitive banking landscape. We’ll explore how First Bancorp’s robust net interest income growth shapes its investment narrative for the months ahead. These 15 companies survived and thrived...

Revolution Medicines has announced updated clinical trial results for elironrasib, its RAS(ON) G12C-selective inhibitor, in heavily pretreated KRAS G12C non-small cell lung cancer patients, reporting a 42% confirmed objective response rate and 79% disease control rate as presented at the AACR-NCI-EORTC Symposium in Boston. The data, released alongside the drug’s Breakthrough Therapy Designation, highlights the potential of elironrasib to address significant unmet needs in advanced lung...

Triumph Financial (NYSE:TFIN) has seen its stock get a boost following a recent upgrade from B. Riley Securities. The company’s momentum is also being driven by its recognition on the FreightWaves 2026 FreightTech 25 list, which highlights its technology-driven progress. See our latest analysis for Triumph Financial. This renewed optimism comes after a stretch of volatility for Triumph Financial, where the share price slid by nearly a third year-to-date but recently rebounded with a strong...

Oruka Therapeutics (ORKA) is drawing investor attention following recent news coverage focused on its progress with clinical-stage monoclonal antibody treatments for psoriasis and inflammatory conditions. Recent developments in its pipeline, particularly regarding ORKA-001, are fueling curiosity. See our latest analysis for Oruka Therapeutics. ORKA’s recent clinical progress has certainly attracted attention, and the share price has responded with a 94.5% return over the past 90 days and a...

Synaptics (SYNA) has rolled out its Astra SL2600 Series, marking a major expansion into Edge AI and IoT hardware. This suite of chips includes advanced AI features and security, targeting everything from smart home devices to industrial automation. See our latest analysis for Synaptics. After unveiling its Astra SL2600 Edge AI processors, Synaptics has seen modest share price movement, with a 2.3% return in the past month and a 5.6% gain over the last 90 days. Still, its 12-month total...

First Horizon (FHN) grabbed investor attention this week as the company reported higher net income and earnings per share for the third quarter. The company also wrapped up a sizable buyback program. See our latest analysis for First Horizon. The recent rally in First Horizon's financial metrics comes against a backdrop of steady, though somewhat tempered, share price momentum. Although the latest share price sits at $20.87 and the year-to-date share price return is 4.35%, the long-term story...

Fair Isaac (FICO) was recently granted 10 new patents. This highlights the company's momentum in Responsible AI, bias detection, and fraud prevention. This expansion reinforces FICO’s capabilities and ongoing innovation across critical technology areas. See our latest analysis for Fair Isaac. FICO’s share price has rebounded sharply in recent weeks, jumping nearly 10% over the past month as the market seems to be taking renewed notice of its steady pipeline of innovation, including its newly...

Krystal Biotech (KRYS) has seen its stock climb about 11% in the past month and gain 22% over the past 3 months. These moves come alongside rising annual revenue and net income, painting a compelling growth story. See our latest analysis for Krystal Biotech. Krystal Biotech’s share price has steadily climbed throughout the year, propelled by robust revenue growth and recent momentum, with a 1-year total shareholder return of 5.2% and a 3-year total return of 143%. The latest gains suggest...

OneSpaWorld Holdings (OSW) has delivered consistent gains for investors over the past year, with its stock up nearly 23%. This comes despite showing slight dips over the month and past 3 months. The company’s financials show healthy revenue and net income growth, sparking interest in its valuation compared to recent performance. See our latest analysis for OneSpaWorld Holdings. Momentum has been cooling a bit after a solid climb, but the big picture for OneSpaWorld Holdings remains...

Tennant (NYSE:TNC) just rolled out its new T360 mid-sized scrubber, a product designed for ease of use and enhanced cleaning efficiency. Investors are eyeing this launch for its potential impact on future sales. See our latest analysis for Tennant. Tennant’s launch of the T360 mid-sized scrubber adds a fresh catalyst for investors, especially as the company has quietly built on strong long-term results. While the past twelve months saw a decline of 8.5% in total shareholder return,...

Freshpet (FRPT) just posted its latest quarterly results, where the company managed to beat EPS and EBITDA estimates even though revenue came in a bit below forecasts. Revenue climbed 12.5% from a year ago, highlighting continued category sales growth as management pointed to ongoing operational improvements. See our latest analysis for Freshpet. Freshpet’s 1-day share price dipped a modest 0.13% after the latest quarterly results, but over the past seven days the stock rebounded with a 4.6%...

Cellebrite DI (NasdaqGS:CLBT) is preparing to present at the International Association of Chiefs of Police Conference in Denver, an event that highlights its growing influence within digital investigations. Investors are watching for signals of future adoption momentum. See our latest analysis for Cellebrite DI. Cellebrite shares have shown notable momentum lately, with a 29% share price return over the last 90 days helping to counteract earlier weakness this year. In a broader context, the...

Autohome (NYSE:ATHM) shares have trended downward over the past month, falling about 11%. With the company showing some annual growth in revenue and earnings, investors are watching closely for any shifts in momentum. See our latest analysis for Autohome. Autohome’s 1-year total shareholder return is down 6.4%, despite a modest 0.85% year-to-date gain in its share price. With a recent 11% drop and a five-year track record that has seen significant declines, investors seem to be weighing the...

On September 30, 2025, BlackRock, Inc. reduced its holdings in CNO Financial Group by 798,252 shares at US$39.55 per share, representing a 6.01% decrease in its position, though it still maintains a significant stake. This shift coincided with analyst commentary highlighting CNO's plateauing revenues and declining profit margins, which may influence how market participants view the company’s outlook. We'll explore how BlackRock's recent adjustment in its CNO position and industry concerns...

In October 2025, Strategic Logix announced it awarded Unusual Machines a record US$12.8 million contract to supply approximately 160,000 drone components for the U.S. Army, marking the company's largest order to date and sparking plans for a new Florida motor factory to meet domestic Pentagon demand. An interesting aspect is that Unusual Machines’ positioning as an NDAA-compliant supplier comes amid heightened U.S. efforts to replace Chinese-made drone components, reinforcing its role as a...

RBC Bearings (RBC) shares have delivered steady gains this year, rising over 38% year to date. Investors are taking notice of the company's double-digit annual revenue and net income growth, which is fueling ongoing interest in its outlook. See our latest analysis for RBC Bearings. RBC Bearings’ strong year-to-date share price return of 38% speaks to increasing market confidence in its ability to sustain growth, especially following its robust double-digit revenue and profit expansion...

Independent Bank (INDB) released its third quarter results, meeting revenue expectations and slightly exceeding earnings forecasts. Management pointed to the completed Enterprise acquisition and improved net interest margin as important factors behind this performance. See our latest analysis for Independent Bank. Independent Bank’s share price has steadily gained momentum this year, climbing 9.5% since January and closing at $69.2 most recently. While the third quarter’s earnings news and...

Interactive Brokers Group (IBKR) has just posted quarterly results that topped expectations, driven by a sharp jump in net income and new account growth. The company rolled out several new technology upgrades. These upgrades may further boost client engagement. See our latest analysis for Interactive Brokers Group. Momentum is definitely building around Interactive Brokers Group, with the share price climbing 2.35% in the past day and a striking 50.68% so far this year. Notably, the company’s...

On October 10, 2025, Legend Biotech announced that the U.S. FDA approved a label update for CARVYKTI® to reflect statistically significant overall survival benefits in relapsed and refractory multiple myeloma, as shown in the Phase 3 CARTITUDE-4 study, and incorporated new safety warnings, including immune effector cell-associated enterocolitis and JC virus reactivation. This development not only highlights longer survival outcomes for patients but also underscores the evolving safety...

AZZ (NYSE:AZZ) is drawing attention after recent analysis highlighted its strong operating margins along with a clear boost in free cash flow margin. Investors are now watching how this efficiency could translate into future investments or shareholder rewards. See our latest analysis for AZZ. AZZ’s latest $98.66 share price reflects a year marked by growing investor confidence. The stock has achieved a 19% share price return so far in 2024 and a 27.39% total shareholder return over the past...

First Industrial Realty Trust recently raised its 2025 earnings guidance to US$1.67–US$1.71 per unit and reported third-quarter sales of US$181.43 million, with net income of US$65.31 million. The upward guidance revision comes as analysts have grown increasingly positive, highlighting broad confidence in the company's position and future prospects despite mixed earnings results. We'll explore how the raised full-year earnings guidance highlights potential changes to First Industrial Realty...

Citius Oncology recently announced it has partnered with McKesson Corporation to make LYMPHIR, an FDA-approved immunotherapy for cutaneous T-cell lymphoma, available nationwide through McKesson’s distribution network. This agreement establishes McKesson as one of the primary authorized distributors for LYMPHIR, further expanding patient access to novel oncology treatments across the United States. We’ll examine how finalizing distribution for this innovative cancer therapy influences...

HNI Corporation recently donated nearly 30 acres of land off University Drive to the city of Muscatine to support residential development aimed at meeting local housing needs. This initiative not only addresses a documented housing shortage but also reflects HNI's focus on community partnership and sustainable growth. We'll explore how HNI's commitment to community development could influence its investment narrative and stakeholder engagement outlook. Explore 28 top quantum computing...